Joshua Aiello

Insider Reports History

Reporting-owner location: New Hope, PA
Latest reporting-owner signature: /s/ Andrew Taylor, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Joshua Aiello

Form 4 holding Principal Accounting Officer

Orchestra BioMed Holdings, Inc.

Security class: Common Stock, par value $0.0001 per share
Shares / value: 18,441
Estimated value: $79,572
Report date: 26 Aug 2026
Price: $4.32
Ownership: Direct

Form 4 holding Principal Accounting Officer

Orchestra BioMed Holdings, Inc.

Security class: Stock Option (Right to Buy)
Shares / value: 70,000
Estimated value
Report date: 12 Feb 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Joshua Aiello

4 OBIO

Orchestra BioMed Holdings, Inc.

Report period: 26 Aug 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 28 Aug 2026, 16:15
Role: Principal Accounting Officer
Next action: Open filing details

4 OBIO

Orchestra BioMed Holdings, Inc.

Report period: 25 Mar 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 27 Mar 2026, 16:30
Role: Principal Accounting Officer
Next action: Open filing details

4 OBIO

Orchestra BioMed Holdings, Inc.

Report period: 12 Feb 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 13 Feb 2026, 17:02
Role: Principal Accounting Officer
Next action: Open filing details

4 OBIO

Orchestra BioMed Holdings, Inc.

Report period: 02 Jan 2026
Transactions: 1
Transaction value: -$1,039
Accepted by SEC: 02 Jan 2026, 18:54
Role: Principal Accounting Officer
Next action: Open filing details

4 OBIO

Orchestra BioMed Holdings, Inc.

Report period: 17 Sep 2025
Transactions: 1
Transaction value: -$499
Accepted by SEC: 19 Sep 2025, 17:31
Role: Principal Accounting Officer
Next action: Open filing details

4 OBIO

Orchestra BioMed Holdings, Inc.

Report period: 07 Aug 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 08 Aug 2025, 19:09
Role: Principal Accounting Officer
Next action: Open filing details

4 OBIO

Orchestra BioMed Holdings, Inc.

Report period: 18 Jun 2025
Transactions: 1
Transaction value: -$1,175
Accepted by SEC: 20 Jun 2025, 16:15
Role: Principal Accounting Officer
Next action: Open filing details

4 OBIO

Orchestra BioMed Holdings, Inc.

Report period: 04 Apr 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 04 Apr 2025, 21:40
Role: Principal Accounting Officer
Next action: Open filing details

4 OBIO

Orchestra BioMed Holdings, Inc.

Report period: 26 Mar 2025
Transactions: 1
Transaction value: -$1,218
Accepted by SEC: 28 Mar 2025, 20:08
Role: Principal Accounting Officer
Next action: Open filing details

4 OBIO

Orchestra BioMed Holdings, Inc.

Report period: 08 May 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 10 May 2024, 17:24
Role: Principal Accounting Officer
Next action: Open filing details

4 OBIO

Orchestra BioMed Holdings, Inc.

Report period: 20 Jul 2023
Transactions: 2
Transaction value: $0
Accepted by SEC: 24 Jul 2023, 17:10
Role: Principal Accounting Officer
Next action: Open filing details

4/A OBIO

Orchestra BioMed Holdings, Inc.

Report period: 26 Jan 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 19 May 2023, 17:40
Role: Principal Accounting Officer
Next action: Open filing details

3 OBIO

Orchestra BioMed Holdings, Inc.

Report period: 26 Jan 2023
Transactions: 0
Transaction value: $0
Accepted by SEC: 30 Jan 2023, 20:17
Role: Corporate Controller and Principal Accounting Officer Exhibit 24 - Power of Attorney
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .